Found: 2
Select item for more details and to access through your institution.
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 3, p. 95, doi. 10.1159/000348522
- By:
- Publication type:
- Article
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 1, p. 128, doi. 10.1002/ijc.34912
- By:
- Publication type:
- Article